裕兴股份 reported revenue of ¥0.45B for the period ended 2026-06-30, -6.1% year on year. Net income was ¥-0.09B, a -19.5% net margin on a -3.3% gross margin. The largest revenue line is 聚酯薄膜 at 90% of the total. Free cash flow for the period was ¥-0.09B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.45B | -6.1% |
| Gross profit | ¥-0.01B | — |
| Operating income | ¥-0.09B | — |
| Net income | ¥-0.09B | — |
| Gross margin | -3.3% | Net margin -19.5% |
| Revenue Q/Q | +32.3% | — |
| Segment | Revenue | Share |
|---|---|---|
| 聚酯薄膜 | ¥0.40B | 89.6% |
| 其他(补充) | ¥0.03B | 6.3% |
| 涂布膜 | ¥0.02B | 4.1% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.46B | 103.3% |
| R&D | ¥0.02B | 4.8% |
| SG&A | ¥0.03B | 6.0% |
| Tax & other | ¥-0.00B | -0.3% |
| Item | Amount |
|---|---|
| Total assets | ¥3.28B |
| Total liabilities | ¥1.30B |
| Shareholders' equity | ¥1.98B |
| Equity / assets | 60.3% |
| Operating cash flow | ¥-0.09B |
| Capital expenditure | ¥0.00B |
| Free cash flow | ¥-0.09B |
| Cash conversion (OCF / net income) | 87% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
远方信息 ・ 慈星股份 ・ 宜通世纪 ・ 任子行 ・ 天山生物 ・ 戴维医疗 ・ 掌趣科技 ・ 珈伟新能 ・ 博晖创新 ・ 麦捷科技 ・ 海达股份 ・ 同大股份
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies